The Presence of MRZ Reactions Improves the Prediction of Multiple Sclerosis in Children with Optic Neuritis

Franziska Kauth1, Sophie Chen1, Eva-Maria Wendel2

  • 1Department of Pediatric Neurology, Children's Hospital Datteln, University Witten/Herdecke, D-45711 Datteln, Germany.

Insights

A positive measles, rubella, and/or varicella-zoster (MRZ) reaction in cerebrospinal fluid predicts conversion from optic neuritis to multiple sclerosis (MS). This MRZ reaction, along with MRI and OCBs, aids in early MS risk assessment in children.

Area of Science:

  • Neurology
  • Immunology
  • Ophthalmology

Background:

  • Optic neuritis (ON) is a rare neurological condition.
  • ON can be a single episode or progress to multiple sclerosis (MS).
  • Oligoclonal bands (OCBs) and spinal MRI lesions are known prognostic factors for MS conversion.

Purpose of the Study:

  • To determine if elevated antibody indices for measles, rubella, and/or varicella-zoster (MRZ) predict conversion from ON to MS.
  • To evaluate the predictive value of MRZ reactions, alone and in combination with other factors, for MS development.

Main Methods:

  • Retrospective study of 228 children diagnosed with ON between 1990 and 2013.
  • Data collected included age, sex, ON type, MRI, cerebrospinal fluid (CSF) studies (OCBs, MRZ reactions), and follow-up of at least 1.5 years.
  • Binary logistic regression and predictive values were used to analyze prognostic factors for MS conversion.

Main Results:

  • MS-like MRI, positive OCBs, and positive MRZ reactions were significant predictors of MS conversion after ON.
  • A positive MRZ reaction alone demonstrated a high predictive value (PPV 0.90) for MS conversion.
  • The combination of cMRI, OCBs, and a positive MRZ reaction achieved the highest predictive value (PPV 1.00).

Conclusions:

  • A positive MRZ reaction is a strong independent predictor of future MS development following ON.
  • The MRZ reaction should be incorporated into the diagnostic workup for children presenting with initial demyelinating events.
  • Early identification of MS risk can potentially guide timely therapeutic interventions.